WDR76 Polyclonal antibody
WDR76 Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
WB, IHC, IF, RIP, ELISA
Conjugate
Unconjugated
Cat no : 25528-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | HeLa cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:200-1:1000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
WB | See 2 publications below |
IHC | See 1 publications below |
IF | See 1 publications below |
RIP | See 1 publications below |
Product Information
25528-1-AP targets WDR76 in WB, IHC, IF, RIP, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | WDR76 fusion protein Ag22114 相同性解析による交差性が予測される生物種 |
Full Name | WD repeat domain 76 |
Calculated molecular weight | 626 aa, 70 kDa |
Observed molecular weight | 70 kDa |
GenBank accession number | BC051855 |
Gene symbol | WDR76 |
Gene ID (NCBI) | 79968 |
RRID | AB_2880120 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
WD40 repeat protein 76 (WDR76) is identified as a novel tumor suppressor and RAS activity can be controlled via regulating protein stability which further affect the tumorigenesis and metastasis in different cancer diseases.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for WDR76 antibody 25528-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Clin Transl Med LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6 A modification in triple-negative breast cancer | ||
Cell Prolif CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation |